Latest News
Breaking news and real-time updates from the ASX small-cap market
Advance Metals Confirms Gold Mineralisation in Maiden Drilling at Queen of the Hills and Sheards Reef
Advance Metals confirms maiden drilling gold mineralisation at Queen of the Hills & Sheards Reef, signalling upside for Myrtleford beyond Happy Valley.
BlinkLab Commences Pivotal FDA 510(k) Validation Program with First Participant Enrolment
BlinkLab kicks off pivotal FDA 510(k) validation for Dx1 autism diagnostic aid; first participant enrolled as an 8-month study targeting end-2026 submission.
How to Become a True ‘Temu Billionaire’
Temu ads promise billionaire riches, but true wealth relies on the equity premium: billionaires hold ~61% of wealth in shares, using volatility for gains.
Cyclopharm to Install Technegas Platform in University of Pennsylvania Health System Network
Cyclopharm inks multi-site UPHS deal to roll Technegas across 11 locations, starting at UPenn. Major US expansion milestone with recurring revenue potential.
The Weekly Finger: Food shopping lists slashed; equities shopping lists get bigger
Markets discount uncertainty; food inflation often hits later - roughly six months to show, with equities exposed to hidden CPI risks beyond oil.
Verity Resources Confirms Gold Mineralisation at Monument’s Triton and Perseverance Prospects
Verity Resources confirms gold mineralisation across 7km of Monument Trend, with Triton and Perseverance showing encouraging results; RC follow-up planned.
Alligator Energy Starts Uranium Extraction as part of Field Recovery Trial at Samphire Project
Alligator Energy starts uranium extraction at Samphire FRT; first uranium-bearing solution flows, marking a milestone toward feasibility study.
Felix Gold Looking to Near-Term Antimony Production with Signing of Alaska Permit
Felix Gold secures Alaska bulk-sampling permit, unlocking near-term antimony at Treasure Creek; dual U.S. path: toll processing H2 2026, smelter 2027.
Cleo Diagnostics Optimises Biomarker Panel for Ovarian Cancer Blood Test Ahead of FDA Submission
Cleo Diagnostics expands ovarian cancer blood test biomarker panel to eight ahead of FDA submission, boosting robustness and paving US market entry (ASX: COV).
Amplia Therapeutics Reports Stronger Efficacy and Survival in Pancreatic Cancer Trial
Amplia Therapeutics reports ACCENT trial: 7.8% CR, 35.9% ORR, 11.1-month median OS in pancreatic cancer; trading halt ahead of AACR.
Kalamazoo Eyes Resource Growth after Strong Gold Intercepts Below Mt Olympus Pit
Kalamazoo Resources hits strong gold intercepts below Mt Olympus at Ashburton; 300m down-plunge, imminent resource definition to exceed 1 Moz Au.
Super Changes Fantastic News for Those on Modest Incomes
Australia's super reforms: LISTO lift aids up to 1.3M workers, adding up to $15k to retirement, while high-balance accounts face higher tax.